TREATMENT OF ULCER BY USING SIDDHA HERBAL FORMULATION OF AMALAKATHI KIRUTHAM
Phase 3
Completed
- Conditions
- Health Condition 1: K00-K95- Diseases of the digestive system
- Registration Number
- CTRI/2021/08/035861
- Lead Sponsor
- ATIONAL INSTITUTE OF SIDDHA
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 30
Inclusion Criteria
Patient with the symptoms of erigunmam such as burning or gnawing sensation in stomach, headache, burping, increased salivation, colic pain, diarrhoea, sweating, giddiness
Exclusion Criteria
pregnancy & Lactation, gastric carcinoma, pancreatitis, liver disorders, worm infestations,abdominal curvature of spine curvature
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcome is mainly assessed by comparing the reduction of clinical symptoms before and after treatment by using GSRS scaleTimepoint: 1 YEAR
- Secondary Outcome Measures
Name Time Method SECONDARY OUTCOME IS ASSESSED BY THE DISEASE RELATED TO AGE,SEX, DIETARY HABITS, SOCIO ECONOMIC STATUS, FAMILY HISTORY ETC, <br/ ><br> <br/ ><br>SECONDARY IS MAINLY ASSESSED BY COMPARING THE CLINICAL SYMPTOMS BEFORE AND AFTER TREATMENT BY USING ENDOSCOPYTimepoint: FOURTY NINTH DAY
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Amalakathi Kirutham's efficacy in treating Erigunmam Acid Peptic Disease?
How does Amalakathi Kirutham compare to proton pump inhibitors in healing gastric ulcers and symptom relief?
Are there specific biomarkers in K00-K95 digestive diseases that predict response to Siddha herbal formulations?
What adverse events were reported in CTRI/2021/08/035861 and how were they managed in Phase III trials?
What are the potential synergistic effects of combining Amalakathi Kirutham with conventional anti-ulcer therapies?